Redox metals and neurodegenerative disease

Current Opinion in Chemical Biology

Volumn 3, Issue 2, 1999, Pages 220-225

  Sayre, Lawrence M ^a   Perry, George ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; COPPER DERIVATIVE; COPPER ZINC SUPEROXIDE DISMUTASE; ENZYME; FREE RADICAL; IRON; IRON DERIVATIVE; MANGANESE; METAL; METALLOPROTEIN; PRION PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ENZYME ACTIVITY; HUMAN; METAL BINDING; METAL METABOLISM; NERVE DEGENERATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; REVIEW; SUBSTANTIA NIGRA;

EID: 0033120504     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(99)80035-0     Document Type: Article

References (48)

1. Smith MA, Sayre LM, Perry G: Primary involvement of oxidative damage and redox imbalance in Alzheimer and other neurodegenerative diseases. In Redox Regulation of Cell Signaling. Edited by Packer L, Yodoi J. New York: Marcel Dekker, Inc; 1988:115-126.
2. Williams MD, Van Remmen H, Conrad CC, Huang TT, Epstein CJ, Richardon A: Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J Biol Chem 1998, 273:28510-28515. Manganese Superoxide dismutase (MnSOD) knockout mice, exhibiting a 50% drop in mitochondrial activity of MnSOD but not CuZnSOD or glutathione peroxidase, witness an increased oxidative damage to mitochondria as shown by increased mitochondrial protein carbonyls and 8-hydroxy-deoxyguanosine in mitochondrial DNA. No damage to cytosolic proteins or to nuclear DNA was observed.
3. Melov S, Schneider JA, Day BJ, Hinerfeld D, Coskun P, Mirra SS, Crapo JD, Wallace DC: A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet 1998,18:159-163. This paper describes a morphological study of manganese superoxide dismutase knockout mice showing mitochondrial welling and axonal vacuolation. Mice die within two weeks of birth.
4. Wang P, Chen H, Qin H, Sankarapandi S, Becher MW, Wong PC, Zweier JL: Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. Proc Natl Acad Sci USA 1998, 95:4556-4560.
5. Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, Reaume AG, Scott RW, Cleveland DW: Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998, 281:1851-1854. In addition to showing, as many previous studies have, that mutant Cu-Zn superoxide dismutase is associated with neurodegenerative damage, the knockout of this enzyme is shown to have no obvious neurodegenerative phenotype.
6. Kwon OJ, Lee SM, Floyd RA, Park JW: Thiol-dependent metal-catalyzed oxidation of copper, zinc superoxide dismutase. Biochim Biophys Acta 1998, 1387:249-256.
7. Harris ZL, Klomp LW, Gitlin JD: Aceruloplasminemia: An inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr 1998, 67(suppl 5):S972-S977.
8. Loeffler DA, LeWitt PA, Juneau PL, Sima AA, Nguyen HU, DeMaggio AJ, Brickman CM, Brewer GJ, Dick RD, Troyer MD, Kanaley L: Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res 1996, 738:265-274.
9. Castellani RJ, Smith MA, Nunomura A, Harris PLR, Perry G: Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? Free Radical Biol Med 1999, in press.
10. Mezzetti A, Pierdomenico SD, Costantini F, Romano F, De Cesare D, Cuccurullo F, Imbastaro T, Riario-Sforza G, Di Giacomo F, Zuliani G, Fellin R: Copper/zinc ratio and systemic oxidant load: Effect of aging and aging-related degenerative diseases. Free Radical Biol Med 1998, 25:676-681.
11. Patel BN, David S: A novel glycosylphosphatidylinositol-anchored from of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem 1997, 272:20185-20190. A novel membrane-bound form of ceruloplasmin (CP) expressed by astrocytes in the mammalian CNS is reported. In the liver, CP is the major Fe(II)-oxidizing enzyme, and this could be the same role for the CP in the CNS, as appears to be the case in aceruloplasminemia. Lack of this form could contribute to neuronal degeneration in Parkinson's disease and Alzheimer's disease.
12. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, von Bohlen A, Schulz-Schaeffer W et al.: The cellular prior protein binds copper in vivo. Nature 1997, 390:684-687. The normal cellular form of prion protein binds Cu(II) nearly as strongly as does serum albumin. Thus, binding of Cu(II) to prion protein may indicate a cytoprotective role of this protein.
13. Brown DR, Schmidt B, Kretzschmar HA: Effects of copper on survival of prion protein knockout neurons and glia. J Neurochem 1998, 70:1686-1693.
14. Pauly PC, Harris DA: Copper stimulates endocytosis of the prion protein. J Biol Chem 1998, 273:33107-33110. Binding of copper to prion protein rapidly and reversibly stimulates its endocytosis from the surface of neuroblastoma cells in culture. This finding suggests that the normal function of this cell-surface glycoprotein may be as a recycling receptor for uptake of extracellular free copper.
15. Wiedau-Pazus M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, Valentine JS, Bredesen DE: Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996, 271:515-518.
16. Andrus PK, Fleck TJ, Gurney ME, Hall ED: Protein oxidative damage in a transgenic mouse model of familial amytrophic lateral sclerosis. J Neurochem 1998, 71:2041 -2048. In familial amylotrophic lateral sclerosis mice overexpressing the Gly93→Ala mutation, there is increased protein carbonyl levels signifying increased hydroxyl radical production and/or lipid peroxidation.
17. Bogdanov MB, Ramos LE, Xu Z, Beal MF: Elevated 'hydroxyl radical' generation in vivo in an animal model of amyotrophic lateral sclerosis. J Neurochem 1998, 71:1321-1324. Using in vivo microdialysis, there is an increase in hydroxyl radicals, as determined by conversion of 4-hydroxybenzoic acid to 3,4-dihydroxybenzoic acid (3,4-DHBA), in the striatum for mice overexpressing mutated Cu,Zn-superoxide dismutase but not for overexpression of the wild type enzyme. 3-Nitropropionic acid increases baseline production of 3,4-DHBA in controls but, whereas the increase was greater in the amyotrophic lateral sclerotic mice, the increase was less in mice overexpressing the wild type enzyme.
18. Ghadge GD, Lee JP, Bindokas VP, Jordan J, Ma L, Miller RJ, Roos RP: Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: Molecular mechanisms of neuronal death and protection. J Neurosci 1998, 17:8756-8766. Expression of Ala4→Val and Val148→Gly Cu, Zn-superoxide dismutase mutants in differentiated neuronal PC12 cells, superior cervical ganglion neurons, and hippocampal pyramidal neurons had higher rates of superoxide production and resulted in cell death exhibiting many features of apoptosis. Cell death could be prevented by copper chelators, Bcl-2, glutathione, vitamin E, and inhibitors of caspases.
19. 2. Proc Natl Acad Sci USA 1998, 95:6675-6680.
20. 2-mediated deactivation.
21. 2. Arch Biochem Biophys 1998, 352:237-239.
22. Corson LB, Strain JJ, Culotta VC, Cleveland DW: Chaperone-faciliated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc Natl Acad Sci USA 1998, 95:6361-6366. An analysis of a broad range of Cu,Zn-superoxide dismutase (SOD) mutants in Saccharomyces cerevisiae was carried out: all appear to bind copper and scavenge superoxide in vivo. These results support a mechanism of SOD1 mutant-mediated disease arising from aberrant copper-mediated chemistry catalyzed by less tightly folded (and less constrained) mutant enzymes. All mutants acquire copper in vivo via action of the copper chaperone for SOD1.
23. Hart PJ, Liu H, Pellegrini M, Nersissian AM, Gralla EB, Valentine JS, Eisenberg D: Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis. Protein Sci 1998, 7:545-555.
24. Kapaki E, Zournas C, Kanias G, Zambelis T, Kakami A, Papageorgiou C: Essential trace element alterations in amyotrophic lateral sclerosis. J Neurol Sci 1997, 147:171-175.
25. 2-dependent oxidation of 3,3′-diaminobenzidine (DAB) or application of Perl's method followed by DAB enhancement. Both Fe(II) and Fe(III) were detected.
26. Yoshida T, Tanaka M, Sotomatsu A, Hirai S, Okamoto K: Activated microglia cause iron-dependent lipid peroxidation in the presence of ferritin. NeuroReport 1998, 9:1929-1933.
27. Double KL, Maywald M, Schmittel M, Riederer P, Gerlach M: In vitro studies of ferritin iron release and neurotoxicity. J Neurochem 1998, 70:2492-2499.
28. Castelnau PA, Garrett RS, Palinski W, Witztum JL, Campbell IL, Powell HC: Abnormal iron deposition associated with lipid peroxidation in transgenic mice expressing interleukin-6 in the brain. J Neuropathol Exp Neurol 1998, 57:268-282.
29. Qian ZM, Wang Q: Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Rev 1998, 27:257-267. Abnormally high levels of iron and oxidative stress have been demonstrated in a number of neurodegenerative disorders, but there is no general agreement as to the causative link between iron-induced oxidative stress and neuronal death. Regulation/management of iron at the cellular level is primarily by the transferrin receptor and ferritin, but recent focus on the roles of the lactotransferrin receptor, melanotransferrin, ceruloplasmin, and divalent cation transporter, suggest that disruption in the expression of these proteins in the brain is probably one of the important causes of altered brain iron metabolism of age-related neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's diseases and amyotrophic lateral sclerosis.
30. 2 to bind iron-responsive elements on mRNA. Characterization of activation in vitro revealed that it does not occur directly, but requires the presence of a cellular membrane-associated component sensitive to temperature and alkaline phosphatase.
31. Smith MA, Wehr K, Harris PLR, Siedlak SL, Connor JR, Perry G: Abnormal localization of iron regulatory protein (IRP) in Alzheimer disease. Brain Res 1998, 788:232-236.
32. Schipper HM: Astrocytes, brain aging, and neurodegeneration. Neurobiol Aging 1996, 17:467-480.
33. Schipper HM, Vininsky R, Brull R, Small L, Brawer JR: Astroctye mitochondria: A substrate for iron deposition in the aging rat substantia nigra. Exp Neurol 1998, 152:188-196.
34. Riederer P, Sofic E, Rausch W-D, Schmidt B, Reynold GP, Jellinger K, Youdim MBH: Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 1989, 52:515-520.
35. Pezzella A, d'Ischia M, Napolitano A, Misuraca G, Prota G: Promediated generation of the neodroxin δ-hydroxdopamine quinone by reaction of fatty acid hydroperoxides with dopamine: A possible contributory mechanism for neuronal degeneration in Parkinson's disease. J Med Chem 1997, 40:2211-2216.
36. Sziráki I, Mohanakumar KP, Rauhala P. Kim HG, Yeh KJ, Chiueh CC: Manganese: A transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of Parkinsonism. Neuroscience 1998, 85:1101-1111.
37. Smith MA, Taneda S, Richey PL, Miyata S, Yan S-D, Stern D, Sayre LM, Monnier VM, Perry G: Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 1994, 91:5710-5714.
38. Smith MA, Harris PLR, Sayre LM, Beckman JS, Perry G: Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997, 17:2653-2657. Neurofibrillary tangle-containing neurons as well as apparently normal hippocampal neurons in Alzheimer disease, but not in controls, exhibit modification by peroxynitrite in the form of protein tyrosine nitration.
39. Smith MA, Sayre LM, Anderson VE, Harris PLR, Beal MF, Kowall N, Perry G: Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with dinitrophenylhydrazine. J Histochem Cytochem 1998, 46:731-735.
40. Sayre LM, Zelasko DA, Harris PLR, Perry G, Salomon RG, Smith MA: 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997, 68:2092-2097. Antibodies selective for the stable, advanced 2-pentylpyrrole modification of protein lysines by 4-hydroxynonenal stain neurofibrillatory tangles (NFT)-containing neurons, extracellular NFT, as well as apparently normal neurons in Alzheimer disease cases but not in controls.
41. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, Smith MA: RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer disease. J Neurosci 1999, in press. Oxidative damage to nucleic acids, leading to 8-hydroxyguanosine (8-OHG), primarily involves cytoplasmic RNA in vulnerable neurons. Neurons with neurofibrillary tangles show reduced damage. The restriction of damage to the cytosol suggests the source of 8-OHG is from metal-dependent formation of the hydroxyl radical.
42. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR: Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998, 158:47-52. Using microparticle-induced X-ray emission, Zn(II), Fe(III) and Cu(II) were found to be significantly elevated in Alzheimer's disease neuropil. These metals are significantly further concentrated within the core and periphery of plaque deposits.
43. Perez M, Valpuesta JM, de Garcini EM, Quintana C, Arrasate M, Lopez Carrascosa JL, Rabano A, Garcia de Yebenes J, Avila J: Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy. Am J Pathol 1998, 152:1531-1539.
44. De Leo ME, Borrello S, Passantino M, Palazzotti B, Mordente A, Daniele A, Filippini V, Galeotta T, Masullo C: Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease. Neurosci Lett 1998, 250:173-176.
45. Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER, Maggio JE: Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J Neurochem 1993, 61:1171-1174.
46. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NME, Romano DM, Hartshorn MA, Tanzi RE, Bush AI: Dramatic aggregation of Altzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 1998, 273:12817-12826. Cu(II) induces aggregation of amyloid β peptide (residues 1-40) (Aβ [1-40]) with slight lowering of pH. This may be a response to local injury. Association of metal with Aβ(1-40) may explain the reported enrichment of Cu(II), Zn(II) and Fe(III) with amyloid plaques in Alzheimer's disease.
47. Bondy SC, Guo-Ross SX, Truong AT: Promotion of transition metal-induced reactive oxygen species formation by β-amyloid. Brain Res 1998, 799:91-96.
48. Multhaup G, Ruppert T, Schlicksupp A, Hesse L, Bill E, Pipkorn R, Masters CL, Beyreuther K: Copper-binding amyloid precursor undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. Biochemistry 1998, 37:7224-7230.